 
<b>Barbiturate dependence</b> develops with regular use of barbiturates. This in turn may lead to a need for increasing doses of the drug to get the original desired pharmacological or therapeutic effect. Barbiturate use can lead to both addiction and physical dependence, and as such they have a high potential for abuse. Psychological addiction to barbiturates can develop quickly. The GABA<sub>A</sub> receptor, one of barbiturates' main sites of action, is thought to play a pivotal role in the development of tolerance to and dependence on barbiturates, as well as the euphoric "high" that results from their abuse. The mechanism by which barbiturate tolerance develops is believed to be different from that of ethanol or benzodiazepines, even though these drugs have been shown to exhibit cross-tolerance with each other. The management of a physical dependence on barbiturates is stabilisation on the long-acting barbiturate phenobarbital followed by a gradual titration down of dose. The slowly eliminated phenobarbital lessens the severity of the withdrawal syndrome and reduces the chances of serious barbiturate withdrawal effects such as seizures. Antipsychotics are not recommended for barbiturate withdrawal (or other CNS depressant withdrawal states) especially clozapine, olanzapine or low potency phenothiazines e.g. chlorpromazine as they lower the seizure threshold and can worsen withdrawal effects; if used extreme caution is required.<p></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist" style="list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Crit_Care_Nurs_Clin-1"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Zapantis A, Leung S (September 2005). "Tolerance and withdrawal issues with sedation". <i>Crit Care Nurs Clin North Am</i>. <b>17</b> (3): 211–23. doi:10.1016/j.ccell.2005.04.011. PMID&nbsp;16115529.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABarbiturate+dependence&amp;rft.atitle=Tolerance+and+withdrawal+issues+with+sedation&amp;rft.aufirst=A&amp;rft.aulast=Zapantis&amp;rft.au=Leung%2C+S&amp;rft.date=2005-09&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccell.2005.04.011&amp;rft_id=info%3Apmid%2F16115529&amp;rft.issue=3&amp;rft.jtitle=Crit+Care+Nurs+Clin+North+Am&amp;rft.pages=211-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display: none;">&nbsp;</span></span></span></li>
<li id="cite_note-Takehiko-2"><span class="mw-cite-backlink">^  </span> <span class="reference-text"><cite class="citation journal">Takehiko Ito; Toshihito Suzuki; Susan E. Wellman; Ing Kang Ho (June 1996). "Pharmacology of barbiturate tolerance/dependence: GABA<sub>A</sub> receptors and molecular aspects". <i>Life Sciences</i>. <b>59</b> (3): 169–95. doi:10.1016/0024-3205(96)00199-3. PMID&nbsp;8699929.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABarbiturate+dependence&amp;rft.atitle=Pharmacology+of+barbiturate+tolerance%2Fdependence%3A+GABA%3Csub%3EA%3C%2Fsub%3E+receptors+and+molecular+aspects&amp;rft.au=Ing+Kang+Ho&amp;rft.au=Susan+E.+Wellman&amp;rft.au=Takehiko+Ito&amp;rft.au=Toshihito+Suzuki&amp;rft.date=1996-06&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0024-3205%2896%2900199-3&amp;rft_id=info%3Apmid%2F8699929&amp;rft.issue=3&amp;rft.jtitle=Life+Sciences&amp;rft.pages=169-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59" class="Z3988"><span style="display: none;">&nbsp;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Allan AM, Zhang X, Baier LD (August 1992). "Barbiturate tolerance: effects on GABA-operated chloride channel function". <i>Brain Res</i>. <b>588</b> (2): 255–60. doi:10.1016/0006-8993(92)91583-Z. PMID&nbsp;1382810.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABarbiturate+dependence&amp;rft.atitle=Barbiturate+tolerance%3A+effects+on+GABA-operated+chloride+channel+function&amp;rft.au=Baier%2C+LD&amp;rft.aufirst=AM&amp;rft.aulast=Allan&amp;rft.au=Zhang%2C+X&amp;rft.date=1992-08&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2F0006-8993%2892%2991583-Z&amp;rft_id=info%3Adoi%2F10.1016%2F0006-8993%2892%2991583-Z&amp;rft_id=info%3Apmid%2F1382810&amp;rft.issue=2&amp;rft.jtitle=Brain+Res.&amp;rft.pages=255-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=588" class="Z3988"><span style="display: none;">&nbsp;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">Tyrer, Peter; Silk, Kenneth R., eds. (24 January 2008). <i>Cambridge Textbook of Effective Treatments in Psychiatry</i> (1st ed.). Cambridge University Press. p.&nbsp;406. ISBN&nbsp;978-0-521-84228-0.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABarbiturate+dependence&amp;rft.btitle=Cambridge+Textbook+of+Effective+Treatments+in+Psychiatry&amp;rft.date=2008-01-24&amp;rft.edition=1st&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DHLPXELjTgdEC&amp;rft.isbn=978-0-521-84228-0&amp;rft.pages=406&amp;rft.pub=Cambridge+University+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display: none;">&nbsp;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">Ebadi, Manuchair (23 October 2007). "Alphabetical presentation of drugs". <i>Desk Reference for Clinical Pharmacology</i> (2nd ed.). USA: CRC Press. p.&nbsp;512. ISBN&nbsp;978-1-4200-4743-1.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABarbiturate+dependence&amp;rft.atitle=Alphabetical+presentation+of+drugs&amp;rft.aufirst=Manuchair&amp;rft.aulast=Ebadi&amp;rft.btitle=Desk+Reference+for+Clinical+Pharmacology&amp;rft.date=2007-10-23&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DihxyHbnj3qYC&amp;rft.isbn=978-1-4200-4743-1&amp;rft.pages=512&amp;rft.place=USA&amp;rft.pub=CRC+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display: none;">&nbsp;</span></span></span></li>
</ol>
</div>
<div class="navbox" role="navigation" aria-labelledby="Psychoactive_substance-related_disorder_.28F10.E2.80.93F19.2C_291.E2.80.93292.3B_303.E2.80.93305.29" style="padding: 3px;">

</div>
<div class="navbox" role="navigation" aria-labelledby="Reinforcement_disorders:_Addiction_and_Dependence" style="padding: 3px;">

</div>
<br><p></p><p></p> 